Rubicon Research IPO listing date has been scheduled for today (Thursday, October 16) on the bourses at 10:00 IST. Rubicon Research IPO allotment was finalised on Tuesday, October 14. According to ...
Starton Holdings plans $40M IPO for cancer drug delivery innovations, but weak IP and limited backing make this a potentially risky investment. Learn more about STA stock here.
India’s IPO market gave mixed results to retail investors in 2025, offering some good lessons in valuation discipline, sectoral resilience, and post-listing strategy. While some companies delivered ...
Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...
Hosted on MSN
Rubicon Research IPO Day 2 LIVE: Issue booked 51% so far; check GMP, subscription status, review. Should you apply?
Rubicon Research IPO Day 2: The initial public offering (IPO) of pharmaceutical company Rubicon Research Ltd enters its second day of bidding process today, 10 October 2025. Rubicon Research IPO ...
Identify research insights to guide research strategy and grow your impact with our Nature Strategy reports. Actionable insights into research performance. Detailed analysis of strengths and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback